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Abstract 
Purpose: To investigate the correlations of the global flash multifocal 
electroretinogram (MOFO mfERG) with common clinical visual assessments – 
Humphrey perimetry and Stratus circumpapillary retinal nerve fiber layer (RNFL) 
thickness measurement in type II diabetic patients.  
Methods: Forty-two diabetic patients participated in the study: ten were free from 
diabetic retinopathy (DR) while the remainder suffered from mild to moderate 
non-proliferative diabetic retinopathy (NPDR). Fourteen age-matched controls were 
recruited for comparison. MOFO mfERG measurements were made under high and 
low contrast conditions. Humphrey central 30-2 perimetry and Stratus OCT 
circumpapillary RNFL thickness measurements were also performed. Correlations 
between local values of implicit time and amplitude of the mfERG components (direct 
component (DC) and induced component (IC)), and perimetric sensitivity and RNFL 
thickness were evaluated by mapping the localized responses for the three subject 
groups.  
Results: MOFO mfERG was superior to perimetry and RNFL assessments in 
showing differences between the diabetic groups (with and without DR) and the 
controls. All the MOFO mfERG amplitudes (except IC amplitude at high contrast) 
correlated better with perimetry findings (Pearson’s r ranged from 0.23 to 0.36, 
p<0.01) than did the mfERG implicit time at both high and low contrasts across all 
subject groups. No consistent correlation was found between the mfERG and RNFL 
assessments for any group or contrast conditions. The responses of the local MOFO 
mfERG correlated with local perimetric sensitivity but not with RNFL thickness. 
Conclusion: Early functional changes in the diabetic retina seem to occur before 
morphological changes in the RNFL.  
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Introduction 
Diabetes mellitus (DM) is a group of systemic disorders resulting in hyperglycemia. 
Vascular anomalies are common complications of DM. The earliest visible signs of 
vascular anomalies in the eyes are microaneurysms, which lead to the diagnosis of 
diabetic retinopathy (DR) [1]. DR is one of the leading causes of blindness in the 
working-age population [2]. 
 
In a rat model, Barber et al. [3-6] demonstrated that neural apoptosis occurs shortly 
after DM is induced. They proposed that neural apoptosis would cause functional and 
anatomical changes of the inner retina even before the existence of visible vascular 
lesions. With the development of new diagnostic instruments, changes in the retinal 
nerve fiber layer (RNFL) thickness have been evaluated in diabetic patients. Optical 
coherence tomography (OCT) is an optical diagnostic instrument which provides an 
objective and non-invasive measurement of cross-sectional retinal thickness. Thinning 
of the neuronal layer has been reported in the human diabetic retina [7-11]. Visual 
function, assessed by automated perimetry, which provides a subjective measurement 
of luminance increment sensitivity at different visual field locations, has also been 
shown to be disturbed before visible DR lesions occur [10,12-15]. These two common 
clinical assessments have been reported to be useful in detecting early changes in 
diabetic retina [7-12,16]. 
 
The full-field flash electroretinogram (Flash ERG) and multifocal electroretinogram 
(mfERG) [17] have been reported to detect functional changes objectively in the 
human diabetic retina at an early stage [18-31]. In our previous study [32], a modified 
global flash mfERG (MOFO mfERG) paradigm was applied to examine early 
functional changes in the diabetic retina. The MOFO mfERG helps in separating the 
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“middle” and “inner” retinal responses. There are two main components in the MOFO 
mfERG response: the direct component (DC) (predominantly from the middle retina) 
and the induced component (IC) (predominantly from the inner retina) [33]. It has 
been found that both the middle and inner retinal functions deteriorate before the 
vascular lesions are visible in DM patients [32]. 
 
In the present study, we aim to compare the findings of our electrophysiological 
assessment with the automated perimetry and the OCT RNFL thickness measurements 
in the diabetic retina, in order to understand their relationships at the early stages of 
DM and to study the difference in the correlations between tests at various levels of 
DR severity.  
 
Methods 
Subjects 
Forty-two patients with type II DM were recruited for the study: Ten (aged 51.0 ± 6.9 
years) were free from DR, while thirty-two (aged 49.5 ± 5.8 years) had 
non-proliferative diabetic retinopathy (NPDR). Fourteen healthy controls (aged 49.4 ± 
7.0 years) were recruited for comparison. All subjects had visual acuity better than 6/9. 
Their refractive errors were between +3.00 D and -6.00 D, and astigmatism was less 
than -1.25 D. Subjects with systemic or ocular diseases other than DM or DR were 
excluded. Detailed eye examination including dilated fundus examination was carried 
out for each subject. One eye was randomly selected for this study.  
 
The instantaneous plasma glucose data were obtained from ten controls and forty 
diabetic patients using a plasma-glucose meter (Accu-Chek Compact Plus, F. 
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Hoffmann-La Roche Ltd, Basel, Switzerland); testing occurred more than 2 h after 
any food intake. 
 
All procedures of the study followed the tenets of the Declaration of Hesinki. This 
study was approved by the Ethics Committee of The Hong Kong Polytechnic 
University. Informed consent was obtained from each subject following full 
explanation of the experimental procedures.  
 
Measurement 
1) mfERG stimulation and recording  
A VERIS Science 5.1 system (Electro-Diagnostic-Imaging, Redwood City, CA, USA) 
was used for the MOFO mfERG measurement. The instrumental set-up was similar to 
that described in our previous studies [32,34,35]. Briefly, the mfERG stimulation was 
a 103 scaled hexagonal pattern, which subtended 47° horizontally and 44° vertically. 
It was displayed on a high luminance CRT monitor (FIMI Medical Electrical 
Equipment, MD0709BRM, Saronno, Italy) with a frame rate of 75 Hz. A cycle of the 
MOFO mfERG stimulation included four video frames: a multifocal flash frame, a 
dark frame, a global flash frame and another dark frame. The multifocal frames were 
modulated between bright and dark phases according to a binary pseudo-random 
m-sequence (213-1). Each subject had the mfERG measurement made at both high 
contrast (98% contrast; bright phase: 200 cd/m2; dark phase: 2 cd/m2) and low 
contrast (46% contrast; bright phase: 166 cd/m2; dark phase: 61 cd/m2) in random 
order with the background luminance of 100 cd/m2. The measurement for each 
contrast level was divided into 32 segments and lasted for about 8 minutes. Short 
breaks were provided between segments. Any segment with blinks or eye movements 
was discarded and re-recorded immediately. 
7 
 
 
One eye of each subject, with the pupil dilated by 1% tropicamide (Alcon, Fort Worth, 
TX, USA), was randomly selected for mfERG measurement. A 
Dawson-Trick-Litzkow (DTL) electrode was used as the active electrode. A gold-cup 
reference electrode was placed 10 mm lateral to the outer canthus of the tested eye, 
and a similar ground electrode was placed on the central forehead. The signal was 
amplified 100,000 times with the bandpass from 3 to 300 Hz (Grass Instrument Co., 
Quincy, MA, USA). The amplitudes and implicit times of the DC and IC for both 
contrast conditions (Fig. 1) were measured as described in previous studies 
[32,34-37]. 
 
2) Optic coherence tomography (OCT) 
The circumpapillary retinal nerve fiber layer (RNFL) thickness was measured by the 
Stratus OCT (Carl Zeiss Meditec, Inc., Dublin, CA, USA) using the fast scanning 
mode. The scanning area was circular with a 3.4 mm diameter. The circle centre was 
aligned with the centre of the optic nerve head. The RNFL thickness within the 
circular region was further divided into 12 sectors, and the sectoral RNFL thickness 
was then used for analysis (see below).  
 
3) Visual field (VF)  
The Humphrey Field Analyzer (Carl Zeiss Meditec, Inc., Dublin, CA, USA) was used 
to measure monocular visual field in this study. The white-on-white static protocol 
“Central 30-2 (SITA-fast)” was chosen to assess the central 60° field; full-aperture 
lenses were placed in front of the patient’s tested eye to correct refractive errors for 
the viewing distance of the VF analyzer. The locations of the VF test spots were 
plotted on a grid; the grid was then overlaid with the mfERG topography, which was 
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divided into 35 regions for further analysis [18,35,38,39]. The overlay is shown as in 
Fig. 2. Details of the grid scaling and alignment are discussed below. 
 
4) Fundus photodocumentation 
A Topcon IMAGEnet fundus camera was used to take fundus photographs of the 
tested eye centrally and at eight peripheral locations for each subject. The photographs 
were then combined to form a mosaic for each subject.  
 
Data analysis 
1) MOFO mfERG parameters 
The 103 mfERG trace arrays were divided into 35 regions as suggested by Bearse et 
al. [18,39]. The mfERG from left eyes was reflected so that all data resembled those 
from right eyes. The amplitudes and implicit times of the local MOFO mfERG 
responses (i.e., DC and IC) were collected for analysis (Fig. 1). For each region, data 
of mfERG parameters from the control group were used to calculate the means and 
standard deviations (SD), which were then used to calculate z-scores of the mfERG 
parameters. Using z-scores for further analysis helps in eliminating topographic 
asymmetry of the mfERG and provides the same basis for comparison [18,35,39-41]. 
Each subject had 35 regional z-scores (calculated based on the regional means and SD 
of the control group) across one’s own mfERG topography. An averaged z-score 
could thus be obtained across the 35 regions for individual subject.  
  
2) Visual field (VF) sensitivity 
In the Humphrey visual field analyzer, two parameters could be obtained directly 
from the printout: mean deviation (MD) and local total deviation (TD). MD is the 
numerical value of averaged VF sensitivity difference from the age-norm provided by 
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the manufacturer of Humphrey analyzer. TD is the numerical value that indicates the 
difference from the age-norm at each tested location on the field. In this study, the 
MD and local TD were used for analysis in order to provide the same basis for 
comparison among different subject groups [42,43]. The MD was correlated with the 
plasma glucose level to evaluate the relationship between and compared among the 
three subject groups. The TD of each VF test spot that fell in the mfERG topography 
was used to map with the mfERG responses in order to evaluate its correlation with 
the electrophysiological assessment. 
 
3) RNFL thickness 
The mean RNFL thickness and the RNFL thickness values obtained in each of the 12 
sectors measured by the OCT within the circular scanning region were used for 
analysis. The averaged RNFL thickness of each subject correlated with the plasma 
glucose level and compared among the three subject groups. To eliminate topographic 
asymmetry, the sectoral RNFL thicknesses of the control group were used to calculate 
the sectoral z-scores for individual subject as suggested by Bronson-Castain et al. [19]. 
At each sector of RNFL thickness, the values from the control group were firstly 
averaged. This value was then used to calculate the sectoral z-score of each subject 
using the following formula: [(Individual sectoral thickness – averaged sectoral 
thickness from controls)/ averaged sectoral thickness from controls]. This provides 
the same basis for comparison among the three groups of regional data after mapping 
between mfERG topography and RNFL profile. 
 
4) Duration of DM, plasma glucose level and averaged findings of the three ocular 
assessments (mfERG, RNFL thickness and VF sensitivity) 
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Duration of DM among the diabetic patients was ranked in 3 categories: less than 5 
years, duration ranged from 5 to 10 years and duration more than 10 years. Median of 
the duration ranking was reported for the diabetic groups in the results below. 
Plasma glucose level and the averaged results of the three ocular assessments were 
compared among the control subjects, the DM patients without DR and the DM 
patients with NPDR using one-way ANOVA; significance levels were adjusted using 
Bonferroni’s correction. Pearson’s correlation (r) was evaluated between the plasma 
glucose level and the averaged mfERG responses, mean RNFL thickness and VF MD 
among the three subject groups.  
 
5) Correlations of the local retinal responses among three ocular assessments by 
mapping 
Fundus photographs, mfERG data and VF data were all provided at different scales. 
They were converted to a common scale by measuring the distance from fovea/ 
fixation point to disk centre/ blindspot depression. This was used as a baseline to 
adjust the scale of the two-dimensional data.  
 
a) Mapping of the fundus photographs with the mfERG topography 
As mentioned above, a mosaic photograph was formed for each individual. By 
overlapping the fovea and optic disk of the photographs with the central peak and 
blindspot depression of the mfERG topography, respectively, the mosaic photographs 
were aligned with the 103-hexagonal mfERG topography. Fundus photographs were 
then divided into 35 regions following the mfERG topography in Fig. 2 [18,39]. A 
retinal specialist who was masked to each patient’s diagnosis then rated each region 
for presence or absence of a DR lesion.  
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This was done for the three groups of subjects, thus allowing creation of three groups 
of regional data: 
Group I – Regional data from the control group only 
Group II – Regional data from the DM patients (without any DR signs) only 
Group III – Regional data from the DM patients with NPDR only, but only those with 
DR lesions were included. Those regions without DR lesions were discarded to avoid 
confusion with group II 
 
b) Mapping of the mfERG topography with the VF test grid 
The 103 hexagonal stimulus pattern of mfERG was aligned with the VF test grid. The 
locations of the blindspot and the fixation point (i.e., foveal peak) in mfERG 
topography were overlaid with the blindspot and fixation point of the VF test grid, 
respectively. By overlaying the VF test grid with the 35-division mfERG topography 
as shown in Fig. 2, the mfERG parameters measured at each division could be 
grouped with the TD of the VF test spot that fell within the division. If more than one 
VF test spot fell within the same mfERG division, the TD of those VF test spots was 
averaged before matching with the mfERG parameters. As the Humphrey central 30-2 
program (central 60°) provides a larger field of view than that of mfERG (~ 47°), 
those VF test spots that fell outside the mfERG topography were excluded from the 
study. Once groupings of mfERG parameters and VF TD values were accomplished, 
correlation values were calculated. 
 
c) Mapping of the mfERG topography with the OCT RNFL thickness profile 
The OCT RNFL profile at the optic disk was mapped with the VF test grid (Fig. 2) 
according to the overlay generated by Garway-Heath et al. [44,45]. The fundus 
locations mapped by Garway-Heath et al. are on a 3° grid, making alignment of their 
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data and ours a simple matter. Together with the mapping applied in the above section 
between the mfERG topography and the VF test grid, we were able to link the MOFO 
mfERG topography to its corresponding sectoral RNFL profile obtained from the 
OCT measurement (Fig. 2). If more than one mfERG division fell along a sector of 
the RNFL profile, the z-scores of the mfERG parameters at that sector were averaged 
before mapping with the RNFL thickness. The correlation between the regional 
MOFO mfERG responses and the sectoral RNFL thickness could then be studied.  
 
d) The correlations (Pearson’s r) between the local z-scores of the MOFO mfERG 
responses and the results of two clinical assessments (VF and OCT) were calculated 
for groups I (regional data from the control group), II (regional data from the DM 
patients without any DR signs) and III (regional data from the DM patients with 
NPDR).  
The regional responses of the three ocular assessments (mfERG, RNFL thickness and 
VF sensitivity) were also compared among groups I, II and III. Due to the repeated 
contribution from individual subject, generalized estimating equation (GEE) with 
Bonferroni’s post hoc adjustment was used for statistical analysis with the assumption 
of unstructured working matrix. 
 
Results 
Correlations of the local mfERG responses with the local sensitivity deviation (TD) of 
VF 
After overlaying the MOFO mfERG topography with VF test spots, there were 76 VF 
test spots that fell into the mfERG topography. This gave a total of 854 VF regional 
data points: 392 in group I, 280 in group II and 182 in group III (Table 1). The 
correlations of the local mfERG responses with the local VF TD are shown in Table 2 
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for different groups of data (Group I, II and III). The mfERG amplitude provides a 
more consistent relationship with the VF findings across various groups than implicit 
time does.  
 
1) MOFO mfERG amplitude z-scores 
At both high and low contrast levels, the DC and IC amplitudes showed a positive 
correlation with VF local sensitivity deviation in all three groups of data (except the 
IC amplitude of group II at high contrast level). Retinal regions with higher luminance 
sensitivity also showed greater mfERG amplitudes. The Pearson’s correlation value 
ranged from 0.24 to 0.42 (p<0.05) (Table 2) (Fig. 3, 4). However, the variations of the 
correlation did not show any trend in terms of the DR lesions or contrast levels. 
 
2) MOFO mfERG implicit time z-scores 
No significant correlations with visual field results were found in the diabetic groups 
(groups II and III) in terms of the DC implicit time at either contrast level. For the IC 
implicit time, significant correlations were found in group II but not in group III at 
high and low-contrast levels. However, the relationship between the IC implicit time 
and luminance sensitivity was inconsistent across the diabetic groups. 
 
Correlations of the local MOFO mfERG responses with the sectoral RNFL thickness 
z-scores 
There were 398 sectoral RNFL thickness z-scores after mapping with the mfERG 
topography: 168 in group I, 120 in group II and 110 in group III (Table 1). However, 
no significant differences were found among these three groups of data (p>0.05). 
The correlations between the mfERG responses with the sectoral RNFL thickness are 
listed in Table 3. No significant trends found in correlations between MOFO mfERG 
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parameters and sectoral RNFL thickness; few statistical significant correlations were 
found between in terms of IC amplitude z-score. However, these correlations were not 
consistent with the changes of contrast levels or among the various subject groups.  
 
Regional data of groups I, II and III from each measurement (MOFO mfERG, VF and 
RNFL) after mapping based on mfERG topography 
For the MOFO mfERG, there were a total of 1074 regional data values: 490 in group I, 
350 in group II and 234 in group III (Table 1).  
 
Only the amplitudes of the DC at low-contrast level and IC at the high contrast level 
were able to differentiate the diabetic data (groups II and III) from the control data 
(group I) (p<0.05). The amplitudes from the diabetic groups were significantly 
smaller than those of the control group. There was a significant delay in high-contrast 
DC and IC for group III (p<0.05), compared to group I data (p<0.05). There was a 
further delay of DC response in group III in high-contrast condition than group II 
(p<0.05). DC and IC implicit time findings did not differentiate between diabetic data 
(groups II and III) and the control data. 
 
Compared with the corresponding VF regional data points after overlaying the MOFO 
mfERG topography with VF test spots as shown in Table 1, it was found that only the 
regions with DR lesions demonstrated a marked reduction in VF sensitivity (p<0.01) 
compared to the regional data from the controls (group I). 
 
However, for the sectoral RNFL thickness z-scores collected after mapping with the 
MOFO mfERG topography (Table 1), no significant differences were found among 
these three groups of data (p>0.05). 
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Relationship of the plasma glucose levels with the averaged mfERG responses, VF 
sensitivity deviation and RNFL thickness 
The control subjects had significantly lower plasma glucose levels than did the 
diabetic patients, either with or without DR (p<0.02 and p<0.01, respectively) (Table 
4).  
 
The MOFO mfERG IC amplitude z-score for the low-contrast condition in the control 
group increased with the plasma glucose level (r=0.731, p<0.02). There were no 
significant correlations between DC or IC amplitude z-scores at either contrast level 
and glucose level for either group of diabetic patients. No significant correlations 
were found between plasma glucose levels and RNFL thickness or VF assessments in 
all groups of subjects (controls, DM patients with or without DR). 
 
Discussion 
Our findings demonstrated that the MOFO mfERG responses generally correlated 
better with the results of perimetric testing than those of the RNFL thickness 
measurement in diabetes. Among these three assessments, only the MOFO mfERG 
differentiates the “No DR” regional data (group II) from the control group (group I). 
The MOFO mfERG amplitude provides a more consistent relationship with the 
clinical perimetric test across retinal regions than does implicit time. RNFL thickness 
has no relationship with the functional testing performed in this study. 
 
We found that the local VF sensitivity deviation (i.e., TD), rather than the RNFL 
thickness, was moderately correlated with most of the MOFO mfERG parameters in 
the control data. It is not surprising that an electrophysiological assessment correlates 
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better with a clinical functional test than with a morphological test in these subjects. 
Visual field assessment has been applied in studies of DM patients, but whether VF 
measures can differentiate diabetic patients without DR from healthy controls is still 
controversial. It is generally accepted that the VF mean deviation should decrease 
with increasing DR severity [10,12,16,46,47].  
 
Two main components are found in the global flash stimulation of the mfERG: the 
direct component (DC) and induced component (IC) [37]. Pharmacological dissection 
of the responses in the porcine eye indicates that the DC component mainly originates 
from the bipolar cells with some oscillatory responses from the inner retina and there 
is little contribution from the photoreceptors. The IC component mainly originates 
from the inner retina, especially the ganglion cells [33]. Under the stimulation with 
less than 60% contrast, the inner retinal response becomes more obvious [48-50]. This 
paradigm has been applied in various ocular diseases to study changes in retinal 
adaptation [25,36,51-53]. 
 
Correlations between mfERG amplitudes and VF parameters were more consistent 
than correlations between implicit time and VF parameters in the diabetic samples 
(groups II and III). Only group II showed a significant negative association between 
the VF and the IC implicit time. There was an opposite change in the correlation 
direction from group I to group II (as shown in Table 2) for the high and low contrast 
conditions. Although the mechanisms for the mfERG amplitude and implicit time 
changes in DM patients are not understood, neither reduced contrast levels nor the 
increased DR severity led to a great change in the values of Pearson’s r between 
MOFO mfERG parameters and VF sensitivity deviations. This result should be 
repeated to determine whether the relationship between VF and IC implicit time can 
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be substantiated or whether it is anomalous. In both previous [25,32,35] and current 
studies, the amplitudes of the MOFO mfERG paradigm demonstrated a greater ability 
in showing the group difference between the healthy and diabetic groups (with or 
without DR); moreover, it also showed a better and more consistent correlation with 
the perimetric functional test than with the implicit time. These findings are different 
to those reported in other mfERG paradigm studies [20,54-57] that delay of implicit 
time existed earlier before the amplitude changes in DM patients. This discrepancy 
between the amplitude and implicit time findings would be probably due to the 
different mfERG paradigms involved in the studies which may in turn trigger a 
different cellular performance. 
 
Similar to a previous study [38], Pearson’s correlation r between the mfERG and VF 
was maintained at about 0.2 to 0.4. The relatively weak to moderate correlations 
between these two functional tests may be due to different underlying mechanisms. 
MOFO mfERG provides an objective measurement of the retinal adaptation activity 
predominantly from retinal components beyond the secondary neural level, while VF 
provides a subjective measurement of the retinal threshold detection from the whole 
visual system. Although the MOFO mfERG was shown to be better than VF in 
differentiating DM patients without DR from the control group, it cannot be 
concluded that mfERG is superior to VF. One of the major differences between VF 
and mfERG is that VF provides a static stimulus for assessing luminance sensitivity 
while mfERG measures activities to luminance changes and temporal interactions. 
The information from these two tests is supplementary and gives rise to a clearer 
picture of the underlying changes in DM. The functional deterioration in the diabetic 
retina found in this study cannot be purely explained by the luminance detection/ 
sensitivity or the morphological changes of the RNFL. The changes observed in 
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MOFO mfERG and its weak to moderate correlations with RNFL thickness and 
luminance sensitivity indicated the alteration of adaptive function in the middle and/or 
inner retinal layers (with the RNFL excluded). 
 
While there are some conservative opinions on the ability of OCT to detect RNFL 
thinning for the DM patients without visible DR lesions [9,11], many studies have 
proposed that there is RNFL thinning, at least in a specific quadrant of the optic disk, 
in the early stages of NPDR [7-9,11,58]. In the present study, functional deterioration 
was found, but no structural anomalies were detected in early DM. Only the IC 
amplitude findings provided a weak correlation with RNFL morphological changes. 
Zhang et al. [59] suggested that retrograde axonal transport was impaired in the early 
stage of DM. The ganglion cells would be adversely affected before morphological 
impairment of the optic nerve fibers. This may indicate why the retinal functional 
deterioration found by the MOFO mfERG paradigm in DM patients does not match 
with RNFL changes, and the optic neuropathy found in DM patients is very different 
from the glaucomatous optic neuropathy [8,9]. This weak 
electrophysiological-morphological association further supports the hypothesis raised 
by Greenstein et al. [60] that the problematic site of DM is at/near the middle retinal 
layers, which is different from glaucoma or retinitis pigmentosa (RP). 
 
Hyperglycemia is an underlying problem in DM. Unexpectedly, the high correlation 
of the plasma glucose level with the IC amplitude in the low-contrast condition was 
shown only in the healthy controls but not in the diabetic patients. This might be due 
to the different effects caused by glycemic control and chronic hyperglycemia 
[10,61,62]. Further studies on how glycemic control and chronic hyperglycemia affect 
middle/inner retinal responses (as reflected in mfERG responses) in both normal and 
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diabetic patients would be useful. Another limitation of this study is the mapping 
between the RNFL bundles with the OCT which was based on a Caucasian population. 
Whether there is any ethnic difference in the mapping of the RNFL to each OCT 
sector needs to be investigated.  
 
Conclusion 
MOFO mfERG results correlated better with the results of the VF test than with the 
morphological findings from the OCT test in diabetic patients. Impairment of retinal 
adaptation can be identified in the early stages of diabetes using the MOFO mfERG. 
The perimetric-electrophysiological association is not strengthened by the existence 
of NPDR.  
 
Impairment of short-term retinal adaptation in early diabetic patients is not related to 
any reduction in RNFL thickness. Further studies with better plasma glucose control 
and measurement should be carried out to investigate the effect of chronic and 
transient hyperglycemia on the visual system. The functional changes in the middle 
and inner retinal layers in the early stages of DM before appearance of visible lesions 
may be a potential target in planning the future treatment of the diabetic retina. 
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Tables 
Table 1. Regional data from each measurement according to its mapping with the MOFO 
mfERG topography 
 Group I Group II Group III 
Visual field (VF) (n= 392) (n= 280) (n= 182) 
Total deviation (TD) -1.51 ± 1.55 -1.84 ± 2.06 -3.30 ± 2.39 (* p=0.005) 
OCT (n= 168) (n= 120) (n= 110) 
Sectoral RNFL thickness (z-
score) 0.00 ± 0.97 0.02 ± 1.25 0.029 ± 1.21 
MOFO mfERG (n= 490) (n= 350) (n= 234) 
98% contrast level (z-scores)    
DCIT _z 0.00 ± 0.96 0.02 ± 1.50 
1.23 ± 1.66 (* p<0.001)  
(† p=0.013) 
DCA_z 0.00 ± 0.96  -0.67 ± 1.01 -0.62 ± 1.09  
ICIT_z 0.00 ± 0.96 0.06 ± 1.68 0.75 ± 2.31 (* p=0.013) 
ICA_z 0.00 ± 0.96 († p=0.045) -0.64 ± 0.85 (* p=0.045) -0.80 ± 0.92 (* p=0.007) 
46% contrast level (z-scores)    
DCIT_z 0.00 ± 0.96 -0.15 ± 1.85 -0.02 ± 2.22 
DCA_z 0.00 ± 0.96 († p=0.014) -0.66 ± 0.90 (* p=0.014) -0.93 ± 1.20  (* p=0.003) 
ICIT_z 0.00 ± 0.96  0.20 ± 1.08  0.12 ± 1.39 
ICA_z 0.00 ± 0.96 -0.12 ± 0.85 -0.47 ± 0.89  
(* Significantly different from the control group (group I) with p< 0.05) 
(† Significantly different from the DM patients without DR (group II) with p<0.05) 
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Table 2. Summary of Pearson’s correlation (r) between local responses of VF (TD) and 
MOFO mfERG parameters 
Contrast 
conditions 
MOFO mfERG 
parameters 
Control Samples 
(Group I) 
No DR Samples 
(Group II) 
DR Samples 
(Group III) 
  Pearson r p-value 
Pearson 
r p-value 
Pearson 
r p-value 
98% DCIT_z 0.26 <0.001* -0.10 0.109 -0.05 0.532 
 DCA_z 0.36 <0.001* 0.28 <0.001* 0.32 <0.001* 
 ICIT_z 0.22 <0.001* -0.20 0.001* 0.03 0.719 
 ICA_z 0.24 <0.001* 0.01 0.909 0.42 <0.001* 
        
46% DCIT_z 0.18 <0.001* 0.09 0.142 0.02 0.794 
 DCA_z 0.25 <0.001* 0.24 <0.001* 0.23 <0.001* 
 ICIT_z 0.16 0.002* -0.22 <0.001* 0.06 0.427 
 ICA_z 0.30 <0.001* 0.23 <0.001* 0.27 <0.001* 
(* Statistically significant level achieved with p< 0.05) 
 
Table 3. Summary of Pearson’s correlation (r) between local responses of RNFL sectoral z-
score and MOFO mfERG parameters 
Contrast 
conditions 
MOFO mfERG 
parameters 
Control Samples 
(Group I) 
No DR Samples 
(Group II) 
DR Samples 
(Group III) 
  Pearson r p-value 
Pearson 
r p-value 
Pearson 
r p-value 
98% DCIT_z -0.08 0.309 -0.09 0.330 0.18 0.067 
 DCA_z 0.02 0.799 0.13 0.159 0.03 0.770 
 ICIT_z -0.05 0.520 -0.06 0.492 0.04 0.718 
 ICA_z -0.06 0.437 0.00 0.995 0.27 0.005* 
        
46% DCIT_z -0.08 0.331 0.07 0.432 0.14 0.139 
 DCA_z -0.14 0.081 -0.00 0.968 -0.08 0.392 
 ICIT_z 0.09 0.233 -0.05 0.596 -0.00 0.966 
 ICA_z -0.20 0.008* -0.06 0.491 -0.15 0.128 
(* Statistically significant level achieved with p< 0.05) 
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Table 4. Summary of the averaged plasma glucose level (mmol/L), the median of the DM 
duration period, the VF mean deviation (dB), the RNFL thickness (um) and the averaged 
MOFO mfERG parameters (z-scores)  
 Control  DM patients without DR  DM patients with NPDR 
 (n= 10persons) (n= 10persons) (n= 30persons) 
Plasma glucose level (mmol/L)  
(Mean ± SD) 6.59 ± 1.58 11.42 ± 4.14 (* p=0.008) 10.15 ± 3.55 (* p=0.018) 
 (n = 14persons) (n = 10persons) (n = 32persons) 
Median of the rank of DM 
duration ------ 2.0 (6.9  6.9years) 1.0 (4.6  3.7years) 
VF mean deviation (dB) -1.46 ± 1.15 -2.01 ± 1.97 -3.15 ± 2.02 (* p=0.017) 
RNFL average thickness (um) (n = 14persons) (n = 10persons) (n = 32persons) 
 114.01 ± 8.94 114.91 ± 12.34 113.26 ± 10.98 
MOFO mfERG (n= 14persons) (n = 10persons) (n = 32persons) 
98% Contrast level (z-scores)    
DCIT_z 0.00 ± 0.70 0.02 ± 1.09 0.42 ± 1.39 
DCA_z 0.00 ± 0.72 -0.67 ± 0.78 -0.59 ± 0.83 
ICIT_z 0.00 ± 0.69 0.06 ± 0.94 0.21 ± 1.15 
ICA_z 0.00 ± 0.74 -0.64 ± 0.60 -0.62 ± 0.66 (* p=0.018) 
46% Contrast level (z-scores)    
DCIT_z 0.00 ± 0.55 -0.15 ± 0.72 0.05 ± 0.94 
DCA_z 0.00 ± 0.71 -0.66 ± 0.49 -0.64 ± 0.69 (* p=0.013) 
ICIT_z 0.00 ± 0.61 0.20 ± 0.57 -0.01 ± 0.68 
ICA_z 0.00 ± 0.78 -0.12 ± 0.39 -0.38 ± 0.48 
(* Significantly different from the control group (Group I) with p< 0.05) 
 
 
Fig. 1 MOFO mfERG resultant waveforms. The measurement of amplitudes and 
implicit times of DC and IC are also shown. 
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Fig. 2 Mapping between the data of the mfERG, VF test and OCT RNFL profile. Left 
side: Mapping of the overlays between the mfERG topography and the VF test spots. 
Right side: The sectoral RNFL profile measured by the OCT. Colour indication: 
Through mapping the VF test spots with the corresponding sectoral RNFL thickness 
according to the studies by Garway-Heath et al. [44,45], the regional mfERG data 
could be matched with the corresponding RNFL thickness (the central red cross 
represents the fixation point of the mfERG and VF assessments) 
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Fig. 3 Correlation between the local responses of the VF (TD) and DCA_z of the 
MOFO mfERG at 98% and 46% contrast conditions for Groups I, II and III 
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Fig. 4 Correlation between the local responses of the VF (TD) and ICA_z of the 
MOFO mfERG at 98% and 46% contrast conditions for Groups I, II and III 
 
